﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Wed, 15 Apr 2026 23:15:55 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/April-2024/rss/1723</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/April-2024/rss/1723" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-12</link><description><![CDATA[  New drug  

 LETIBOTULINUMTOXINA-wLBG 
(Letybo—Hugel Inc.) 

  Drug class:  Letybo is a cetylcholine release inhibitor. 

  Indication:  Letybo is indicated for the temporary improvement in ...]]></description><pubDate>Sun, 07 Apr 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-12</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2132]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Get ready: COVID-19 therapeutics transition to the commercial market]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/get-ready-covid-19-therapeutics-transition-to-the-commercial-market</link><description><![CDATA[  Clarissa Chan, PharmD  

 As pandemic uncertainty dissipates, COVID-19 therapeutics are transitioning from U.S. government–procured sources to the commercial market. Health care providers—and ...]]></description><pubDate>Sun, 07 Apr 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/get-ready-covid-19-therapeutics-transition-to-the-commercial-market</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2126]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Barriers still present for OUD medications even after passage of MAT Act]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/barriers-still-present-for-oud-medications-even-after-passage-of-mat-act</link><description><![CDATA[  Parth Patel, PharmD  

   

 Even after passage of the Mainstreaming Addiction Treatment (MAT) Act in late 2023, patients still face difficulty gaining access to buprenorphine—the gold standard ...]]></description><pubDate>Sun, 07 Apr 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/barriers-still-present-for-oud-medications-even-after-passage-of-mat-act</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2127]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Use of gabapentin in U.S. shows no sign of slowing]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/use-of-gabapentin-in-us-shows-no-sign-of-slowing</link><description><![CDATA[  Elizabeth Briand  

   

 Gabapentinoid use has continued to climb in the United States, despite a lack of strong evidence for its effectiveness in pain management and other uses, according to ...]]></description><pubDate>Sun, 07 Apr 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/use-of-gabapentin-in-us-shows-no-sign-of-slowing</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2129]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Prebiotics: A gut check]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/prebiotics-a-gut-check</link><description><![CDATA[  Mickle Cathers  

   

 Prebiotic dietary supplements boast that they promote digestive health, reduce inflammation, increase energy and drive, and may help with appetite control. All this and ...]]></description><pubDate>Sun, 07 Apr 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/prebiotics-a-gut-check</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2130]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Muscle aches and pain]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/muscle-aches-and-pain</link><description><![CDATA[  Mary Warner  

   

 Everyone experiences muscle pain (myalgia) at some point in their lives, whether due to overexertion, injury, or disease. Fortunately, numerous options, including rest, ...]]></description><pubDate>Sun, 07 Apr 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/muscle-aches-and-pain</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2131]]></dc:identifier></item></channel></rss>